Abstract
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with onset in the early thirties. The disease is characterized by inflammation, destruction of the myelin coating of nerve fibres and axonal loss that lead to symptoms such as visual and sensory disturbances, limb weakness, gait problems and neurogenic bladder and bowel symptoms, all of which become increasingly disabling over time. Irreversible functional disability occurs early, making MS the second most common cause of neurological disability in young adults.